 |
 |
GUIDELINES FOR THE SUBMISSION OF ABSTRACTS
Abstract submission is closed.
Participants interested in presenting an oral or a poster presentation
are invited to submit an abstract.
To ensure rapid evaluation and processing procedures of the presentation,
the organizers would like to encourage electronically submission of abstracts.
Abstract submission is closed.
In case of genuine difficulties please contact the meeting secretariat:
coronary@kenes.com,
or email your abstract as WORD file attachement. In that case do NOT forget
to complete the information requested as shown on this page.
Authors must strictly adhere to the instruction, otherwise abstracts
cannot be considered for presentation.
All abstracts will be reviewed by the Scientific Committee and may be
accepted for oral or poster presentation, or may be rejected. Accepted
abstracts will be published in The Journal of Coronary Artery Disease.
Author of selected abstracts will also be invited to contribute a chapter
to the Proceedings of the Congress which will be published in book form.
Instructions
- Complete the information requested on the Abstract
Submission Form
- Please follow the order: Title, Initials and full surname of presenting
author and co-authors, institute/hospital, city, country and text
- The abstract title should be brief and specific, please do not use
abbreviations
- There is space for approximately 250 words
- DO NOT use special fonts such as italics, underline and bold, or special
characters, trademark symbols or mathematical symbols
- Use only one form per abstract.
- Schemes, flow charts and pictures are not accepted
- The abstract should substantially outline the content of the presentation,
including conclusion.
Disclosure Of Faculty Relationships - Policy Statement
The Congress requires that audiences at this educational program be informed
of a presenter's academic and professional affiliations, as well as other
commercial relationships relevant to the content of the material that
is presented. This policy allows the listener/attendee to be fully informed
in evaluating the information being presented. The situations may include,
but are not limited to
| 1. |
stock options or bond holdings |
| 2. |
research grants |
| 3. |
employment (full or part time) |
| 4. |
ownership or partnership |
| 5. |
consulting fees or other remuneration
received by the presenter or his/her immediate family |
| 6. |
nonremunerative positions of influence
such as officer, board member, trustee, or public spokesperson. The
disclosure should be shown (by an* in the authors list) for those
presenters who have stated that a relationship(s) exists relevant
to the topic(s) being discussed. |
Abstract Categories
Select one category, under which your abstract will be reviewed:
1. Basic research, molecular biology
2. Angiogenesis, gene therapy
3. Acute myocardial infarction
4. Angina pectoris: stable angina
5. Angina pectoris: unstable angina, ACS
6. Arrhythmias, EKG, pacing, electrophysiology
7. Atherosclerosis, lipids, lipoproteins
8. Computer applications
9. Diagnosis, diagnostic methods
10. Drug therapy
11. Endothelial function, vascular biology
12. Epidemiology, prevention, risk factors
13. Heart failure
14. Hypertension
15. Interventional cardiology: general
16. Interventional: brachytherapy, drug eluting stents
17. Intracoronary flow, Doppler, ultrasound (IVUS)
18. Myocardium: molecular biology
19. Myocardium: viability, hibernation, stunning
20. Myocardium: ventricular function
21. Neurohormonal aspects
22. Practice patterns, guidelines
23. Prognosis, progression
24. Surgical aspects
|
